Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial

Renal Function ◽

Liver Transplant ◽

Study Protocol ◽

De Novo ◽

Controlled Trial ◽

Early Initiation ◽

Transplant Recipients ◽

Randomized Controlled ◽

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial

American Journal of Transplantation ◽

10.1111/j.1600-6143.2012.04212.x ◽

2012 ◽

Vol 12 (11) ◽

pp. 3008-3020 ◽

Cited By ~ 198

Author(s):

P. De Simone ◽

F. Nevens ◽

L. De Carlis ◽

H. J. Metselaar ◽

S. Beckebaum ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

De Novo ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955076.793461374 ◽

2012 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Renal Function ◽

Liver Transplant ◽

De Novo ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

180 EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL

Journal of Hepatology ◽

10.1016/s0168-8278(13)60182-8 ◽

2013 ◽

Vol 58 ◽

pp. S79-S80 ◽

Cited By ~ 2

Author(s):

F. Saliba ◽

H.J. Metselaar ◽

S. Beckebaum ◽

C. Duvoux ◽

M. Navasa ◽

...

Keyword(s):

Liver Transplant ◽

De Novo ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

Liver Transplantation ◽

10.1002/lt.21314 ◽

2007 ◽

Vol 13 (12) ◽

pp. 1694-1702 ◽

Cited By ~ 75

Author(s):

Christopher J.E. Watson ◽

Alexander E.S. Gimson ◽

Graeme J. Alexander ◽

Michael E.D. Allison ◽

Paul Gibbs ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

Impaired Renal Function ◽

Calcineurin Inhibitor ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients

Vaccine ◽

10.1016/j.vaccine.2021.03.063 ◽

2021 ◽

Author(s):

Mari Eriksson ◽

Helena Käyhty ◽

Mika Lahdenkari ◽

Heikki Mäkisalo ◽

Veli-Jukka Anttila

Keyword(s):

Liver Transplant ◽

Controlled Trial ◽

Repeated Dose ◽

Transplant Recipients ◽

Adult Liver ◽

Randomized Controlled ◽

Liver Transplant Recipients ◽

Conjugate Vaccination

CMV Antigenemia Directed Preemptive Prophylaxis with Oral Ganciclovir for the Prevention of CMV Disease in Liver Transplant Recipients: A Prospective, Randomized, Controlled Trial.

Transplantation Journal ◽

10.1097/00007890-199805131-00440 ◽

1998 ◽

Vol 65 (Supplement) ◽

pp. 189

Author(s):

N SINGH ◽

V L YU ◽

T GAYOWSKI ◽

I R MARINO

Keyword(s):

Liver Transplant ◽

Controlled Trial ◽

Oral Ganciclovir ◽

Transplant Recipients ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial ◽

Cmv Disease ◽

Liver Transplant Recipients ◽

Cmv Antigenemia

Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial

Infection and Drug Resistance ◽

10.2147/idr.s222934 ◽

2020 ◽

Vol Volume 13 ◽

pp. 89-98

Author(s):

Mojtaba Shafiekhani ◽

Iman Karimzadeh ◽

Saman Nikeghbalian ◽

Mohammad Firoozifar ◽

Gholamreza Pouladfar ◽

...

Keyword(s):

Liver Transplant ◽

Bacterial Infections ◽

Controlled Trial ◽

Transplant Recipients ◽

Post Transplant ◽

Randomized Controlled ◽

Early Calcineurin Inhibitors Elimination Improves Renal Function in De Novo Heart Transplant Recipients: The Results of a Randomized Controlled Trial (SCHEDULE Trial).

Transplantation Journal ◽

10.1097/00007890-201407151-00005 ◽

2014 ◽

Vol 98 ◽

pp. 3 ◽

Cited By ~ 1

Author(s):

V. Sigurdardottir ◽

A. Andreassen ◽

F. Gustafsson ◽

H. Eiskjaer ◽

G. Radegran ◽

...

Keyword(s):

Renal Function ◽

Heart Transplant ◽

De Novo ◽

Controlled Trial ◽

Calcineurin Inhibitors ◽

Transplant Recipients ◽

Randomized Controlled ◽

Heart Transplant Recipients

CMV Antigenemia Directed Preemptive Prophylaxis with Oral Ganciclovir for the Prevention of CMV Disease in Liver Transplant Recipients: A Prospective, Randomized, Controlled Trial

Transplantation Journal ◽

10.1097/00007890-199806270-00461 ◽

1998 ◽

Vol 65 (12) ◽

pp. S113 ◽

Cited By ~ 3

Author(s):

N SINGH ◽

V L YU ◽

T GAYOWSKI ◽

I R MARINO

Keyword(s):

Liver Transplant ◽

Controlled Trial ◽

Oral Ganciclovir ◽

Transplant Recipients ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial ◽

Cmv Disease ◽

Liver Transplant Recipients ◽

Cmv Antigenemia

Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study

BMC Nephrology ◽

10.1186/1471-2369-11-24 ◽

2010 ◽

Vol 11 (1) ◽

Cited By ~ 8

Author(s):

Andreas A Schnitzbauer ◽

Marcus N Scherer ◽

Justine Rochon ◽

Johannes Sothmann ◽

Stefan A Farkas ◽

...

Keyword(s):

Renal Function ◽

Pilot Study ◽

Liver Transplant ◽

Study Protocol ◽

Impaired Renal Function ◽

De Novo ◽

Transplant Recipients ◽

Mtor Inhibition ◽

Safety And Efficacy ◽